Some interesting commentary on the Amarex debacle.
Post# of 154231
(Total Views: 523)
Posted On: 12/07/2021 7:22:29 PM
Re: Buddyboy20 #111833
Some interesting commentary on the Amarex debacle. From YMB:
RANTES
$CYDY conversation
Makes you wonder if big pharma was involved indirectly somehow???
Amarex’s integration into the NSF family coincided with a deterioration of the relationship
between CytoDyn and Amarex, as CytoDyn learned that Amarex has failed to perform certain of
its responsibilities under the MSA, work orders, and monitoring plan. Id. ¶ 39. Amarex also covered up its failures by making false statements to CytoDyn about the work it performed and by
failing to provide CytoDyn with information to which it is entitled. Id. ¶ 42. Despite these failings,
Amarex has continued to submit invoices for work that CytoDyn does not believe Amarex actually
performed, and for work that it did not perform in compliance with the MSA, work orders, and
Case 8:21-cv-02533-PJM Document 33 Filed 12/07/21 Page 3 of 12
4
relevant standards. Id. ¶ 53. CytoDyn has therefore refused to pay Amarex for a number of outstanding invoices. Id. Nonetheless, Amarex continues to demand payment under the invoices and
has refused to do any more work, until CytoDyn pays the outstanding invoices. Id. ¶ 14.3"
RANTES
$CYDY conversation
Makes you wonder if big pharma was involved indirectly somehow???
Amarex’s integration into the NSF family coincided with a deterioration of the relationship
between CytoDyn and Amarex, as CytoDyn learned that Amarex has failed to perform certain of
its responsibilities under the MSA, work orders, and monitoring plan. Id. ¶ 39. Amarex also covered up its failures by making false statements to CytoDyn about the work it performed and by
failing to provide CytoDyn with information to which it is entitled. Id. ¶ 42. Despite these failings,
Amarex has continued to submit invoices for work that CytoDyn does not believe Amarex actually
performed, and for work that it did not perform in compliance with the MSA, work orders, and
Case 8:21-cv-02533-PJM Document 33 Filed 12/07/21 Page 3 of 12
4
relevant standards. Id. ¶ 53. CytoDyn has therefore refused to pay Amarex for a number of outstanding invoices. Id. Nonetheless, Amarex continues to demand payment under the invoices and
has refused to do any more work, until CytoDyn pays the outstanding invoices. Id. ¶ 14.3"
(1)
(0)